openPR Logo
Press release

Anticonvulsants for Neuropathic Pain Market - Strategies Endorse by major players 2025 | Teva Pharmaceuticals, Depomed Inc.

09-27-2018 09:01 AM CET | Health & Medicine

Press release from: TMR Research

Anticonvulsants for Neuropathic Pain Market - Strategies Endorse by major players 2025 | Teva Pharmaceuticals, Depomed Inc.

Global Anticonvulsants for Neuropathic Pain Market: Snapshot

Neuropathic pain, which refers to kind of chronic pain resulting from an injury to or disease of the central or peripheral nervous system, remains a therapeutic challenge to clinicians as it does not respond well to conventional pain therapies. Although the clinical knowledge regarding the pathogenesis of the condition has significantly increased over the past few decades, the actual mode of action of most popular treatment mechanisms and the pathogenesis of neuropathic pain remain somewhat unclear.

Owing to the several similarities between the pathophysiological symptoms observed in neuropathic pain models and in some epilepsy models, anticonvulsants are finding increased usage in the symptomatic management of neuropathic pain conditions. Carbamazepine, the world’s first anticonvulsant examined in clinical trials, continues to remain one of the key choices of healthcare practitioners for neuropathic pain conditions. Apart from carbamazepine, a number of new anticonvulsants in the market or in high quality clinical trials represent a new era in the treatment of neuropathic pain.

Request Sample Copy of the Report @ www.tmrresearch.com/sample/sample?flag=B&rep_id=32

The overall role of anticonvulsants in the treatment of neuropathic pain continues to evolve. Further advances in the overall understanding of the mechanisms of neuropathic pain conditions and well-designed clinical trials are expected to further improve the opportunities to make anticonvulsants an established course of action in the treatment of neuropathic pain. This report examines the current state of development of the global market for anticonvulsants, with applications in the treatment of neuropathic pain at the center of focus. Recent developments and future scope of development of the market are also analyzed.

Global Anticonvulsants for Neuropathic Pain Market: Overview

Neurapthic pain (NP) is a severe pain associated with a number of diseases such as cancer, diabetes, and herpes zoster. This pain affects almost 1% of the world’s total population and is aggravated as a result of dysfunction, lesion, or transitory perturbation in the peripheral and central nervous system. Some other causes of neuropathic pain include trigeminal neuralgia, peripheral and entrapment neuropathy, brachial plexus avulsion pain, spinal cord injury pain, post-herpetic neuralgia, arachnoiditis, phantom limb pain, and post-stroke pain.

Request TOC of the Report @ www.tmrresearch.com/sample/sample?flag=T&rep_id=32

The report presents a definitive analysis of market drivers, market restraints, and trends that will impact progression of the global anticonvulsants for neuropathic pain market until the end of 2025. The report charts the developmental growth map in the future by analyzing the past performance of the market.

The research report analyzes the global anticonvulsants for neuropathic pain market from a competitive viewpoint as well. The report finds out how innovations and product development will present growth opportunities to market players to serve niche patient areas. The analysis of changing competitive hierarchy is presented through graphs and pictorial representations. The report is compiled after collecting data from industry-centric databases and scrutinized using validated analytical tools.

Read Comprehensive Overview of Report @ www.tmrresearch.com/anticonvulsants-for-neuropathic-pain-...

Global Anticonvulsants for Neuropathic Pain Market: Drivers and Restraints

The increasing incidence of people with neuropathic pain is one of the major factors driving the anticonvulsants for neuropathic pain market. In addition, a high number of patients refractory to alternate treatment methods, increasing use of generic drugs compared to branded drugs, and a high rate of polypharmacy are some other factors driving the growth of this market.

The development of novel drug molecules for neuropathic drug indications is also propelling the growth of this market. This is because less than 50% of the patients respond to existing drugs that are available for neuropathic drug indications. Moreover, these drugs are associated with a number of side effects, particularly when administered systemically. Hence, new drug variants that can provide convincing action mechanism will be a game changer in the global neuropathic pain market.

Some of the newer anticonvulsant drugs for neuropathic pain include Depomed’s Gralise (gabapentin gastric-retention), which is available since 2011 and is a ‘once –daily’ formulation. XenoPort’s Horizant (gabapentin encarbil) was introduced in 2012 and is a “twice-daily’ formulation.

Global Anticonvulsants for Neuropathic Pain Market: Advantages of Anticonvulsants

Neuropathic pain can be managed by opioids such as morphine, non-steroidal anti-inflammatory drugs, and anticonvulsant drugs. Anticonvulsants are normally used to control epileptic seizures but may also be used for treating neuropathic pain conditions such as fibromyalgia and postherpetic neuralgia.

Companies Mentioned in report

The report provides a detailed vendor landscape of the global anticonvulsants for neuropathic pain market with a business profile of major companies that operate in this market. These are Teva Pharmaceuticals, Depomed Inc., Janssen Pharmaceutical Inc., Cephalon Inc., GlaxoSmithKline plc, Novartis AG, Pfizer Inc., AbbVie Inc., and XenoPort Inc.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anticonvulsants for Neuropathic Pain Market - Strategies Endorse by major players 2025 | Teva Pharmaceuticals, Depomed Inc. here

News-ID: 1265940 • Views: 230

More Releases from TMR Research

Laboratory Equipment Services Market - Survey On Potential Players 2025 | Danahe …
Global Laboratory Equipment Services Market: Snapshot Laboratory may refer to a type of facility where controlled conditions are provided to carry out technological or scientific research, measurements, and different experiments. The several equipment and tools that are used by researchers or scientists who are working in a laboratory are referred to as laboratory equipment. Laboratory equipment are of several types such as glassware such as reagent bottle, beaker, spectrophotometers, autoclave, microscope,
Burn Care Market - Overview Global Trends 2025 | Deroyal Industries, Inc., Medtr …
Burn Care Market: Snapshot Patients suffering from burns are increasingly demanding procedures to improve their physical appearance. There is a rising demand for minimally invasive procedures for enhancing the cosmetic appeal so that patients can lead a normal life without having to face embarrassment. The rising disposable income of the people is creating a heightened demand for treatment options so that patients can regain confidence. The willingness to spend high amounts
Antidiuretic Drugs Market - Evolution Landscape 2028 | Avadel, Ferring B.V., Nov …
Global Antidiuretic Drugs Market: Overview The global market for antidiuretic drugs has been rising on account of advancements in the field of pharmaceutical formulations. The use of antidiuretic drugs in the field of animal-care has played a crucial role in the growth of the global market in recent times. Maintaining fluid balance in animal bodies is integral to their health and functioning. The masses have shown increasing concerns towards the health
Splenomegaly Therapeutics Market - Product Review By Experts 2028 | Novartis AG, …
Global Splenomegaly Therapeutics Market: Overview The demand within the global market for splenomegaly therapeutics has been rising on account of advancements in the field of spleen-care. Unusual enlargement of the spleen due to a variety of reasons results in a condition known as splenomegaly. The adverse effects of splenomegaly on human health have paved way for the growth of the global splenomegaly therapeutics market. The spleen is located upper left quadrant

All 25903 Releases


More Releases for Anticonvulsants Neuropathic Pain

Anticonvulsants for Neuropathic Pain Market unprovoked by 2025
Global Anticonvulsants for Neuropathic Pain Market: Snapshot Neuropathic pain, which refers to kind of chronic pain resulting from an injury to or disease of the central or peripheral nervous system, remains a therapeutic challenge to clinicians as it does not respond well to conventional pain therapies. Although the clinical knowledge regarding the pathogenesis of the condition has significantly increased over the past few decades, the actual mode of action of most
Anticonvulsants for Neuropathic Pain Market Business Strategy & Forecast by 2025
Global Anticonvulsants for Neuropathic Pain Market: Snapshot Neuropathic pain, which refers to kind of chronic pain resulting from an injury to or disease of the central or peripheral nervous system, remains a therapeutic challenge to clinicians as it does not respond well to conventional pain therapies. Although the clinical knowledge regarding the pathogenesis of the condition has significantly increased over the past few decades, the actual mode of action of most
Anticonvulsants for Neuropathic Pain Market : Key Trends and Forecast Research R …
Global Anticonvulsants for Neuropathic Pain Market: Snapshot Neuropathic pain, which refers to kind of chronic pain resulting from an injury to or disease of the central or peripheral nervous system, remains a therapeutic challenge to clinicians as it does not respond well to conventional pain therapies. Although the clinical knowledge regarding the pathogenesis of the condition has significantly increased over the past few decades, the actual mode of action of most
Anticonvulsants for Neuropathic Pain Market: Industry Survey and Outlook 2025
Global Anticonvulsants for Neuropathic Pain Market: Snapshot Neuropathic pain, which refers to kind of chronic pain resulting from an injury to or disease of the central or peripheral nervous system, remains a therapeutic challenge to clinicians as it does not respond well to conventional pain therapies. Although the clinical knowledge regarding the pathogenesis of the condition has significantly increased over the past few decades, the actual mode of action of most